arrow
I

Issa Nébié

groupe de recherche action en sante
H指数:47
被引数:5,817

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Five-Year Experience of the Groupe de Recherche Action en Santé (GRAS) Clinical Laboratory, Burkina Faso, in Participating into an External Proficiency Testing (EPT) Programme

布基纳法索Groupe de Recherche Action en Santé (GRAS)临床实验室参与外部能力验证计划(EPT)五年的经验

2025-12-230
OAAI
A Multiplex Serological Assay to Evaluate the Antibody Responses to a Set of Plasmodium falciparum Antigens and Their Protective Role Against Malaria in Children Aged 1.5 to 12 Years Living in a Highly Seasonal Malaria Transmission Area of Burkina Faso

一种多重血清学检测方法,用于评估对一组 *Plasmodium falciparum* 抗原的抗体反应及其在布基纳法索高度季节性疟疾传播区域中,对1.5至12岁儿童的保护作用。

2025-10-240
OAAI
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa

重组Plasmodium vivax蛋白rPvs48/45与来自非洲Plasmodium falciparum流行区血浆的交叉反应性

2025-03-180
OA
Comparative evaluation of plasma biomarkers of Schistosoma haematobium infection in endemic populations from Burkina Faso
2024-09-180
OAAI
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults
2024-04-012
OAAI
Phase 1b randomized, controlled, double-blinded, age de-escalation trial to evaluate the safety, reactogenicity and immunogenicity of BK-SE36/CpG malaria vaccine in Burkinabe healthy adults and children
2023-12-170
OA
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
2023-10-166
OAAI
A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
2022-12-0721
OA
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children
2022-08-319
OAAI
Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections
2021-04-2650
OAAI